Statistics for A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
Total visits
| views | |
|---|---|
| A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease | 247 |
Total visits per month
| views | |
|---|---|
| January 2025 | 3 |
| February 2025 | 1 |
| March 2025 | 1 |
| April 2025 | 5 |
| May 2025 | 2 |
| June 2025 | 1 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Weir_2017_US.pdf | 597 |
| java.util.UUID:7b7662e8-60dc-4fe5-a1a6-fc5611b24a43 | 94 |
| java.util.UUID:f9e1e640-a9aa-4012-9815-b2efffe92da9 | 18 |
| java.util.UUID:0a06c330-bf6a-4340-a47d-bca428fedb96 | 3 |
Top country views
| views | |
|---|---|
| United States | 179 |
| Germany | 7 |
| Ukraine | 7 |
| China | 5 |
| Russia | 5 |
| United Kingdom | 4 |
| Thailand | 3 |
| Canada | 2 |
| India | 2 |
| Mexico | 2 |
| Switzerland | 1 |
| Czechia | 1 |
| Italy | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Poland | 1 |
| Singapore | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 52 |
| Fairfield | 23 |
| Houston | 14 |
| Ann Arbor | 11 |
| Jacksonville | 7 |
| Kiev | 7 |
| Cambridge | 6 |
| Kiez | 6 |
| Beijing | 3 |
| Moscow | 3 |
| San Francisco | 3 |
| Washington | 3 |
| Arkadelphia | 2 |
| Baltimore | 2 |
| Bangkok | 2 |
| Mumbai | 2 |
| Saint Petersburg | 2 |
| Seattle | 2 |
| Toronto | 2 |
| Basel | 1 |
| Bloomington | 1 |
| Brooklyn | 1 |
| Columbia | 1 |
| Columbus | 1 |
| Fort Washington | 1 |
| Guadalajara | 1 |
| Gunzenhausen | 1 |
| Hanoi | 1 |
| Irvine | 1 |
| Lake Mary | 1 |
| Mexico City | 1 |
| Monmouth Junction | 1 |
| Nanjing | 1 |
| Overland Park | 1 |
| Philadelphia | 1 |
| Rome | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Uherske Hradiste | 1 |
| White Plains | 1 |
| Woburn | 1 |
| Yongin-si | 1 |